Fecha de publicación: 14/01/2025 Fuente: FierceBiotech Welcome to Day 2 of the J.P. Morgan Healthcare Conference 2025 in San Francisco. Yesterday saw some high-value dealmaking, including one of the biggest acquisitions in recent JPM memory, when Johnson & Johnson snapped up neuro biopharma Intra-Cellular for a cool $14.6 billion.